Apotex Health Corp. (APTX:TSX) closed at $39.44 on November 13, 2026, up 2.55% on the day. The stock trades 1.8% below its 52-week high of $40.18 and 51.4% above its 52-week low of $26.05. Over the past year, it gained 46.1%. Apotex Health Corp. is part of the Health Care sector.
In 108 trading sessions since June 11, 2026, APTX closed higher on 58 days (54%). Its best day was June 26, 2026 (+8.35%) and its worst was September 15, 2026 (-9.35%). It never moved 10% or more in a single session.
Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.
Find more stocks like APTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.